Molecular basis of beta-thalassemia minor in Taiwan.

Abstract:

:The mutations producing beta-thalassemia minor in 227 Taiwanese were studied using the method of naturally and amplified created restriction sites. beta-Thalassemia minor was caused by one beta-globin gene mutation in most of the cases (225/227); only a few cases were caused by two gene mutation (2/227). The most common type of mutation was frameshift codon 41/42 (-TCTT) (93/227), followed in descending order by the C-->T substitution at nucleotide 654 of IVS-2 (83/227), the nonsense mutation A--T at codon 17 (22/227), the A-->T mutation at position -28 of the promotor region (12/227), the frameshift codon 27/28 (+C) (6/227), the initial codon mutation (ATG-->AGG) (5/227), and one each of the codon 71/72 (+A), IVS-1 nt 1 (G-->T), IVS-1 3' end (TAG-->GAG), and nonsense codon 43. In the two cases of the two-gene mutation, one was the nt 654 mutation with Hb Kaohsiung and another one was frameshift codon 41/42 with Hb Meinung. The first four mutations accounted for more than 90% of the mutations. The C-->T substitution at the nt 654 of IVS-2 and initial codon mutation in our study had a higher incidence than in other Southeast Asia areas. Comparison of clinical data in different types of beta-thalassemia showed that there were higher MCV and MCH levels in beta (+)-thalassemia.

journal_name

Int J Hematol

authors

Chang JG,Lin CP,Liu TC,Chiou SS,Chen PH,Lee LS,Chen TP

subject

Has Abstract

pub_date

1994-06-01 00:00:00

pages

267-72

issue

4

eissn

0925-5710

issn

1865-3774

journal_volume

59

pub_type

杂志文章
  • Impaired fibrinolytic capacity in rheumatic mitral stenosis with or without atrial fibrillation and nonrheumatic atrial fibrillation.

    abstract::Chronic atrial fibrillation (AF) has often been associated with systemic embolization, and patients with mitral stenosis (MS) have the highest thromboembolic risk. Increased risk of thromboembolism could be in part due to impaired fibrinolytic function. Global fibrinolytic capacity (GFC) is an innovative technique for...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02982584

    authors: Atalar E,Ozmen F,Haznedaroğlu I,Ozer N,Aksöyek S,Ovünç K,Nazli N,Kirazli S,Kes S

    更新日期:2002-08-01 00:00:00

  • No V(H) somatic hypermutation was detected in B-cells of a patient with macroglobulinemia due to splenic marginal zone lymphoma.

    abstract::B-cell diseases are classified on the basis of the normal differentiation stages. We report here a case of a patient with a long history of leukocytosis, splenomegaly without lymphadenopathy, and hyperviscosity symptoms. Clinically, the patient's diagnosis was leukemic Waldenstrom macroglobulinemia. Chromosomal analys...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02982811

    authors: Sekikawa T,Takahara S,Kawano T,Nakada S,Ito K,Iwase S,Yamada H,Kobayashi M,Horiguchi-Yamada J

    更新日期:2002-12-01 00:00:00

  • A fatal case of cytomegalovirus ventriculoencephalitis in a mycosis fungoides patient who received multiple umbilical cord blood cell transplantations.

    abstract::Cytomegalovirus (CMV) infection is latent in the majority of adult humans. The reactivation of CMV causes pneumonia and gastrointestinal disease in severely immunosuppressed patients, who consequently suffer very high mortality due to CMV central nervous system disease. We report here a case involving a 28-year-old fe...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-012-1003-3

    authors: Matsukawa T,Goto H,Takahashi K,Asanuma S,Yasumoto A,Takahata M,Shigematsu A,Endo T,Tanaka J,Hashino S,Tanaka S,Imamura M

    更新日期:2012-02-01 00:00:00

  • Predictors of anxiety and depression in Egyptian thalassemic patients: a single center study.

    abstract::Thalassemic patients are vulnerable to emotional and behavioral problems. Each patient age group exhibits problems unique to that stage of development, and although up to 80 % of thalassemic patients are likely to have psychological disorders, e.g., anxiety and depression, predictors of these disorders remain poorly u...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-013-1322-z

    authors: Yahia S,El-Hadidy MA,El-Gilany AH,Anwar R,Darwish A,Mansour AK

    更新日期:2013-05-01 00:00:00

  • Relative increase in lymphocytes from as early as 1 month predicts improved response to dasatinib in chronic-phase chronic myelogenous leukemia.

    abstract::Lymphocytosis in response to dasatinib for chronic myelogenous leukemia (CML) may be associated with favorable response. However, it occurs at varying times and in a limited subset of patients. To identify early clinical markers for favorable responses applicable to all patients with or without lymphocytosis, we prosp...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-013-1483-9

    authors: Kumagai T,Matsuki E,Inokuchi K,Ohashi K,Shinagawa A,Takeuchi J,Yoshida C,Okamoto S,Wakita H,Kozai Y,Shirasugi Y,Fujisawa S,Iwase O,Yano S,Nishiwaki K,Oba K,Sakamoto J,Sakamaki H

    更新日期:2014-01-01 00:00:00

  • Promoter hypermethylation of the DNA-repair gene O6-methylguanine-DNA methyltransferase and p53 mutation in diffuse large B-cell lymphoma.

    abstract::The gene for the DNA-repair enzyme O6-methylguanine-DNA methyltransferase (MGMT), which is closely related with cellular sensitivity to alkylating agents, is inactivated by promoter hypermethylation in several human cancers, including malignant lymphoma. Promoter hypermethylation of the MGMT gene is a favorable progno...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1532/IJH97.06087

    authors: Hiraga J,Kinoshita T,Ohno T,Mori N,Ohashi H,Fukami S,Noda A,Ichikawa A,Naoe T

    更新日期:2006-10-01 00:00:00

  • Gene therapy of X-linked severe combined immunodeficiency.

    abstract::Severe combined immunodeficiency (SCID) conditions appear to be the best possible candidates for a gene therapy approach. Transgene expression by lymphocyte precursors should confer to these cells a selective growth advantage that gives rise to long-lived T-lymphocytes. This rationale was used as a basis for a clinica...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/BF02982686

    authors: Hacein-Bey-Abina S,Fischer A,Cavazzana-Calvo M

    更新日期:2002-11-01 00:00:00

  • Intravascular large B-cell lymphoma with involvement of the abdominal subcutis: a case report and literature review.

    abstract::Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of diffuse large B-cell lymphoma (DLBCL). It commonly presents with a variety of symptoms due to occlusion of small vessels by tumor cells in different organ systems. Clinically patients may present with generalized symptoms such as fever and malaise. In w...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/s12185-009-0262-0

    authors: Yin W,Li M,Gao Z,Huang F,Da J,Liu C

    更新日期:2009-04-01 00:00:00

  • Geographic clustering of myeloma in Tokushima.

    abstract::Between 1978-1988, seven cases of multiple myeloma were found in T Town (population 9,000), which is located at the mouth of a large river within the boundaries of Tokushima City, Japan. This is a significantly high incidence, 7.06 per 100,000 as compared with an incidence of 1.20 in Tokushima City itself and 1.53 in ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Kosaka M,Okagawa K,Miyamoto Y,Goto T,Saito S

    更新日期:1991-10-01 00:00:00

  • FLT3 antibody-based therapeutics for leukemia therapy.

    abstract::Antibodies represent a unique class of therapeutics because of their high specificity toward a defined target antigen. Recent clinical success with antibody-based cancer therapeutics has led to an upsurge in the development of these agents. Antibodies directed against FLT3 represent a promising approach for the treatm...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1532/IJH97.05068

    authors: Li Y,Zhu Z

    更新日期:2005-08-01 00:00:00

  • Alternatives to conventional or myeloablative chemotherapy in myelodysplastic syndrome.

    abstract::At present, the only 2 treatments that can prolong survival in patients with myelodysplastic syndrome (MDS) are allogeneic stem cell transplantation and intensive chemotherapy. Alternatives to myeloablative or conventional chemotherapy include: (1) supportive therapy, (2) stimulation of normal residual hematopoietic p...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:

    authors: Cazzola M

    更新日期:2000-08-01 00:00:00

  • Successful cord blood transplantation for mycosis fungoides.

    abstract::A 26-year-old female diagnosed as mycosis fungoides (MF, clinical stage IV) was treated with single-agent chemotherapy, multi-drug chemotherapy and unrelated bone marrow transplantation with reduced-intensity conditioning (engraftment failure), resulting in failure. Unrelated cord blood transplantation (CBT) as second...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-008-0190-4

    authors: Fukushima T,Horio K,Matsuo E,Imanishi D,Yamasaki R,Tsushima H,Imaizumi Y,Ohshima K,Hata T,Yoshida S,Miyazaki Y,Tomonaga M

    更新日期:2008-12-01 00:00:00

  • Expression of myeloperoxidase and gene mutations in AML patients with normal karyotype: double CEBPA mutations are associated with high percentage of MPO positivity in leukemic blasts.

    abstract::The percentage of myeloperoxidase (MPO)-positive blast cells is a simple and highly significant prognostic factor in AML patients. It has been reported that the high MPO group (MPO-H), in which >50% of blasts are MPO activity positive, is associated with favorable karyotypes, while the low MPO group (≤50% of blasts ar...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-011-0883-y

    authors: Tominaga-Sato S,Tsushima H,Ando K,Itonaga H,Imaizumi Y,Imanishi D,Iwanaga M,Taguchi J,Fukushima T,Yoshida S,Hata T,Moriuchi Y,Kuriyama K,Mano H,Tomonaga M,Miyazaki Y

    更新日期:2011-07-01 00:00:00

  • Expression levels of ASNS in mesenchymal stromal cells in childhood acute lymphoblastic leukemia.

    abstract::Increased levels of asparagine synthetase (ASNS), an enzyme producing intracellular asparagine, have been implicated in the development of asparaginase resistance. The aim of this study was to assess ASNS mRNA and protein expression in bone marrow cell populations of children with acute lymphoblastic leukemia (ALL). B...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-014-1509-y

    authors: Dimitriou H,Choulaki C,Perdikogianni C,Stiakaki E,Kalmanti M

    更新日期:2014-03-01 00:00:00

  • Myeloid/natural killer cell precursor acute leukemia accompanied by homozygous protein C deficiency.

    abstract::A patient with myeloid/natural killer (NK) cell precursor acute leukemia who was also homozygous for protein C deficiency was treated and showed a complete remission while he simultaneously received low molecular weight heparin. He presented with fever spikes, lymphadenopathy, and a bulky tumor of the anterior mediast...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02983384

    authors: Shimamoto T,Nakajima A,Katagiri T,Ito Y,Ohyashiki K

    更新日期:2003-08-01 00:00:00

  • Unique association of Waldenström macroglobulinemia with optic neuritis and monoclonal T cell expansion.

    abstract::Waldenström macroglobulinemia is a lymphoplasmacytic lymphoma characterized by production of the immunoglobulin M (IgM) monoclonal protein. Commonly involved sites are the bone marrow, lymph nodes, and spleen. Lymphoplasmacytic infiltration of the central nervous system (CNS), in contrast, is referred to as Bing-Neel ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-013-1372-2

    authors: Morita K,Yoshimi A,Masuda A,Ichikawa M,Yatomi Y,Kurokawa M

    更新日期:2013-08-01 00:00:00

  • T-cell posttransplant lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.

    abstract::Posttransplant lymphoproliferative disorder (PTLD) after allogeneic hematopoietic cell transplantation (HCT) is usually donor derived, associated with Epstein-Barr virus (EBV), and of B-cell origin. T-cell PTLD (T-PTLD) after allogeneic HCT is extremely rare. Four of 1015 (0.39%) allogeneic HCT patients were diagnosed...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-020-02890-1

    authors: Kuno M,Ito A,Maeshima AM,Taniguchi H,Tanaka T,Inamoto Y,Kurosawa S,Kim SW,Fukuda T

    更新日期:2020-08-01 00:00:00

  • Treatment of radiculomyelopathy in two patients with placenta-derived decidua stromal cells.

    abstract::Mesenchymal stromal cells may reverse acute inflammatory disorders. The placenta is important in feto-maternal tolerance. We have used placenta-derived decidua stromal cells (DSCs) to treat graft-versus-host disease and found an immunomodulatory and anti-inflammatory effect. We here report the use of DSCs in two patie...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-019-02804-w

    authors: Sadeghi B,Ersmark B,Moretti G,Mattsson J,Ringdén O

    更新日期:2020-04-01 00:00:00

  • Establishment of an HS23 stromal cell-dependent myeloma cell line: fibronectin and IL-6 are critical.

    abstract::A multiple myeloma (MM) cell line, MSG1, which depends on HS23 stromal cells for its survival, was established from the pleural effusion of a patient with MM who expressed the M-protein of IgA-λ in his serum. During the first 2 months of culture, the myeloma cells survived on adhesive cells from the pleural effusion a...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-010-0698-2

    authors: Sakai A,Oda M,Itagaki M,Yoshida N,Arihiro K,Kimura A

    更新日期:2010-11-01 00:00:00

  • Exogenously expressed granulocyte colony-stimulating factor (G-CSF) receptor on K562 cells can transduce G-CSF-triggered growth and differentiation signals.

    abstract::Human granulocyte colony-stimulating factor (G-CSF) receptor cDNA was introduced into the erythroleukemic cell line K562, which normally does not express the receptor, using lipofection transfection of a G-CSF receptor expression plasmid vector. Transfected cells expressed the receptor with a dissociation constant of ...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1016/0925-5710(95)00352-s

    authors: el-Sonbaty SS,Watanabe M,Hochito K,Yamaguchi K,Matsuda I,Tsuchiya H

    更新日期:1995-02-01 00:00:00

  • Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients.

    abstract::There is an ongoing search for potential biomarkers for acute myeloid leukemia (AML) patients using metabolic analysis. However, only few studies to date have focused on bone marrow samples or a specific subtype of AML. In the present study, we used gas chromatography time-of-flight mass spectrometry of plasma and bon...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-020-02836-7

    authors: Zhou X,Zheng M,Wang Q,Aa J,Cao B,Li J

    更新日期:2020-06-01 00:00:00

  • Use of PCR serum in diagnosing and monitoring cytomegalovirus reactivation in bone marrow transplant recipients.

    abstract::We previously reported that the use of polymerase chain reaction (PCR) in detecting cytomegalovirus (CMV) DNA in serum (sPCR) enables the detection of CMV viremia, which has not been possible with other methods. In this study, the clinical usefulness of sPCR was investigated by comparison with the results of three oth...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Matsunaga T,Sakamaki S,Ishigaki S,Kohda K,Takeda M,Katoh J,Kuroda H,Hirayama Y,Kusakabe T,Akiyama T,Kuga T,Niitsu Y,Masaoka T,Sagawa T,Matsumoto Y

    更新日期:1999-02-01 00:00:00

  • A prospective study of cyclosporine A treatment of patients with low-risk myelodysplastic syndrome: presence of CD55(-)CD59(-) blood cells predicts platelet response.

    abstract::Although immunosuppressive therapy using antithymocyte globulin or cyclosporine A (CSA) is effective in selected patients with low-risk myelodysplastic syndrome, the response rates reported so far are inconsistent, and the indication of immunosuppressive therapy for myelodysplastic syndrome has not been clearly define...

    journal_title:International journal of hematology

    pub_type: 杂志文章,多中心研究

    doi:10.1532/IJH97.07052

    authors: Ishikawa T,Tohyama K,Nakao S,Yoshida Y,Teramura M,Motoji T,Takatoku M,Kurokawa M,Mitani K,Uchiyama T,Omine M

    更新日期:2007-08-01 00:00:00

  • An increase in MPC-1- and MPC-1-CD45+ immature myeloma cells in the progressive states of bone marrow plasmacytosis: the revised phenotypic classification of monoclonal marrow plasmacytosis (MOMP-2005).

    abstract::The heterogeneity of bone marrow plasmacytosis is clearly analyzed by multicolor staining with anti-CD38 antibody. To date, at least 5 subpopulations of plasma cells have been identified in the bone marrow of multiple myeloma (MM) patients with regard to the expression of MPC-1, CD49e (VLA-5), and CD45: MPC-1(-)CD49e(...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1532/IJH97.05112

    authors: Otsuyama K,Asaoku H,Kawano MM

    更新日期:2006-01-01 00:00:00

  • 10-year complete remission in a Philadelphia chromosome-positive acute lymphoblastic leukemia patient using imatinib without high-intensity chemotherapy or allogeneic stem cell transplantation.

    abstract::The outcome of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph-ALL) has improved with the use of tyrosine kinase inhibitors, such as imatinib and dasatinib. We report a 63-year-old woman with Ph-ALL who maintained complete remission for 10 years using imatinib without high-intensity chemotherapy or a...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-017-2382-2

    authors: Fujimaki K,Hattori Y,Nakajima H

    更新日期:2018-06-01 00:00:00

  • Successful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor.

    abstract::A 32-year-old male patient with severe factor VIII (FVIII) deficiency had developed a high-titer FVIII inhibitor at age 13. Recurrent hemarthroses caused bony destruction in both knees, significantly impairing his ability to walk. Knee examination revealed 20 degrees of varus, destruction of the medial joint line, and...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/BF02981987

    authors: Carr ME Jr,Loughran TP,Cardea JA,Smith WK,Kuhn JG,Dottore MV

    更新日期:2002-01-01 00:00:00

  • Association of src-kinase Lyn and non-src-kinase Syk with the granulocyte colony-stimulating factor receptor (G-CSFR) is not abrogated in neutrophils from severe congenital neutropenia patients with point mutations in the G-CSFR mRNA.

    abstract::Severe congenital neutropenia (SCN) is characterized by a maturation arrest of myeloid progenitor cells at the stage of promyelocytes in bone marrow and low levels of mature neutrophils in peripheral blood. To date, little is known regarding the underlying pathomechanism of SCN. A defective response of neutrophil prec...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:

    authors: Kasper B,Tidow N,Welte K

    更新日期:1999-12-01 00:00:00

  • Once-weekly vs. twice-weekly carfilzomib dosing in a subgroup of Japanese relapsed and refractory multiple myeloma patients from a randomized phase 3 trial (A.R.R.O.W.) and comparison with ENDEAVOR.

    abstract::A.R.R.O.W. evaluated the superiority of once-weekly carfilzomib plus dexamethasone (Kd) 20/70 mg/m2 vs. twice-weekly Kd 20/27 mg/m2 based on progression-free survival (PFS) in relapsed and/or refractory multiple myeloma patients. Forty Japanese patients (once-weekly arm, n = 26; twice-weekly arm, n = 14) were randomiz...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-020-03013-6

    authors: Takezako N,Shibayama H,Handa H,Hagiwara S,Ozaki S,Suzuki K,Kosugi H,Ri M,Sugiura I,Choi I,Miyamoto T,Iida S

    更新日期:2020-10-10 00:00:00

  • Ofatumumab combined with chlorambucil for previously untreated chronic lymphocytic leukemia: a phase I/II, open-label study in Japan.

    abstract::Elderly/comorbid patients with chronic lymphocytic leukemia (CLL) require low-toxicity treatments. Internationally, the standard treatment for such patients is chlorambucil and an anti-CD20 therapy; however, chlorambucil is not approved in Japan. The aim of the present study was to evaluate the safety, efficacy and ph...

    journal_title:International journal of hematology

    pub_type: 杂志文章

    doi:10.1007/s12185-017-2233-1

    authors: Hatake K,Ogura M,Takada K,Taniwaki M,Zhang F,Fujita T,Ando K

    更新日期:2017-08-01 00:00:00

  • Ras/MAPK syndromes and childhood hemato-oncological diseases.

    abstract::Noonan syndrome (NS) is an autosomal-dominant disease characterized by distinctive facial features, webbed neck, cardiac anomalies, short stature and cryptorchidism. NS exhibits phenotypic overlap with Costello syndrome and cardio-facio-cutaneous (CFC) syndrome. Germline mutations of genes encoding proteins in the RAS...

    journal_title:International journal of hematology

    pub_type: 杂志文章,评审

    doi:10.1007/s12185-012-1239-y

    authors: Aoki Y,Matsubara Y

    更新日期:2013-01-01 00:00:00